05.06.2025
Latest News
Iktos brings Makya, its AI-Driven Drug Design Tool, to the AWS Marketplace
Iktos is pleased to announce it has become an Advanced Technology Partner in the AWS Partner Network and joined the AWS ISV (Independent Software Vendor) Accelerate co-sell program. As part of this collaboration, Iktos has made Makya, its innovative de novo drug design tool, available on the AWS Marketplace.
Press release
Press articles and news
Nine promising small molecule drug discovery companies to look out for in 2025
We are proud to be featured in Labiotech.eu’s roundup of “9 Small Molecule Drug Discovery Companies to Look Out for in 2025”!
Press Kit
Contact
For any communication need please contact our agency.
Ulysse Communication
Mail : iktosteam@ulysse-communication.com
Tel. : +33663665922
